AU2002210404A1 - A composition or rose hip and fish oil for alleviating joint pain and stiffness - Google Patents
A composition or rose hip and fish oil for alleviating joint pain and stiffnessInfo
- Publication number
- AU2002210404A1 AU2002210404A1 AU2002210404A AU1040402A AU2002210404A1 AU 2002210404 A1 AU2002210404 A1 AU 2002210404A1 AU 2002210404 A AU2002210404 A AU 2002210404A AU 1040402 A AU1040402 A AU 1040402A AU 2002210404 A1 AU2002210404 A1 AU 2002210404A1
- Authority
- AU
- Australia
- Prior art keywords
- stiffness
- fish oil
- composition
- joint pain
- rose hip
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
Abstract
A daily administration of a rose-hip concentrate and fish oil is used to treat and/or alleviate the symptoms associated with joint disease such as osteoarthritis, specifically joint pain and stiffness. By administering the combination on a daily basis, a significant reduction in pain and stiffness of the joints affected by joint disease is attained which allows individuals suffering from joint disease to substantially resume daily activities.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09694764 | 2000-10-23 | ||
US09/694,764 US6485752B1 (en) | 2000-10-23 | 2000-10-23 | Composition and method for alleviating joint pain and stiffness |
PCT/DK2001/000696 WO2002034274A1 (en) | 2000-10-23 | 2001-10-22 | A composition or rose hip and fish oil for alleviating joint pain and stiffness |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002210404A1 true AU2002210404A1 (en) | 2002-05-06 |
Family
ID=24790170
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002210404A Abandoned AU2002210404A1 (en) | 2000-10-23 | 2001-10-22 | A composition or rose hip and fish oil for alleviating joint pain and stiffness |
Country Status (11)
Country | Link |
---|---|
US (1) | US6485752B1 (en) |
EP (1) | EP1337263B1 (en) |
AT (1) | ATE387212T1 (en) |
AU (1) | AU2002210404A1 (en) |
CY (1) | CY1107930T1 (en) |
DE (1) | DE60133030T2 (en) |
DK (1) | DK1337263T3 (en) |
ES (1) | ES2301565T3 (en) |
PT (1) | PT1337263E (en) |
SI (1) | SI1337263T1 (en) |
WO (1) | WO2002034274A1 (en) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8633246B2 (en) * | 2003-08-11 | 2014-01-21 | Hill's Pet Nutrition, Inc. | Omega-3 fatty acids for osteoarthritis |
US8633247B2 (en) | 2003-08-11 | 2014-01-21 | Hill's Pet Nutrition, Inc. | Method for decreasing cartilage damage in dogs |
US7758902B2 (en) * | 2003-09-12 | 2010-07-20 | Access Business Group International Llc | Cytokine modulators and related methods of use |
KR101245440B1 (en) * | 2003-09-12 | 2013-03-19 | 액세스 비지니스 그룹 인터내셔날 엘엘씨 | Cytokine modulators and related method of use |
US7758903B2 (en) | 2003-09-12 | 2010-07-20 | Access Business Group International Llc | Cytokine modulators and related methods of use |
US8075910B2 (en) * | 2004-05-20 | 2011-12-13 | Pbm Pharmaceuticals, Inc. | Oral compositions comprising edible oils and vitamins and/or minerals and methods for making oral compositions |
US20060088596A1 (en) | 2004-09-28 | 2006-04-27 | Atrium Medical Corporation | Solubilizing a drug for use in a coating |
US9801982B2 (en) | 2004-09-28 | 2017-10-31 | Atrium Medical Corporation | Implantable barrier device |
US9012506B2 (en) | 2004-09-28 | 2015-04-21 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
US9000040B2 (en) | 2004-09-28 | 2015-04-07 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
EP1811935B1 (en) | 2004-09-28 | 2016-03-30 | Atrium Medical Corporation | Heat cured gel and method of making |
US9278161B2 (en) | 2005-09-28 | 2016-03-08 | Atrium Medical Corporation | Tissue-separating fatty acid adhesion barrier |
US9427423B2 (en) | 2009-03-10 | 2016-08-30 | Atrium Medical Corporation | Fatty-acid based particles |
KR20090033470A (en) * | 2006-07-14 | 2009-04-03 | 디에스엠 아이피 어셋츠 비.브이. | Compositions comprising rosehip and other active agents for the treatment of inflammatory disorders |
US20080031869A1 (en) * | 2006-08-02 | 2008-02-07 | Fontaine Juliette S | Pain relief composition |
EP2626091B1 (en) | 2006-11-06 | 2016-09-28 | Atrium Medical Corporation | Coated surgical mesh |
US9492596B2 (en) | 2006-11-06 | 2016-11-15 | Atrium Medical Corporation | Barrier layer with underlying medical device and one or more reinforcing support structures |
US20080207756A1 (en) * | 2007-02-27 | 2008-08-28 | Atrium Medical Corporation | Bio-absorbable oil suspension |
MX2010006955A (en) | 2007-12-21 | 2010-12-14 | Finzelberg Gmbh & Co Kg | Preparations with rosehip extracts, and method of producing rosehip extracts. |
MX2010011922A (en) * | 2008-05-06 | 2011-03-02 | Finzelberg Gmbh & Co Kg Star | Cistus extract containing enriched secondary plant ingredients. |
WO2010048955A1 (en) * | 2008-10-30 | 2010-05-06 | Hyben Vital Licens Aps | Composition comprising a glycoside of a mono- or diacyiglycerol compound and an oil rich in n-3 polyunsaturated fatty acids, a method of producing the composition and use of the composition |
US20100215781A1 (en) * | 2009-02-25 | 2010-08-26 | Joar Opheim | Therapeutic composition comprising omega-3 polyunsaturated fatty acid or derivative thereof, resveratrol and green tea |
US20110038910A1 (en) | 2009-08-11 | 2011-02-17 | Atrium Medical Corporation | Anti-infective antimicrobial-containing biomaterials |
US20110045050A1 (en) * | 2009-08-24 | 2011-02-24 | Atrium Medical Corporation | Nanoemulsion formulations for direct delivery |
DK177605B1 (en) | 2010-03-16 | 2013-11-18 | Hyben Vital Licens Aps | Compositions of rose hips enriched with seeds of rose hips and their use as anti-inflammatory natural medicine for alleviating/reducing symptoms associated with inflammation and joint diseases such as arthritis and/or osteo-arthritis |
EP2593141B1 (en) | 2010-07-16 | 2018-07-04 | Atrium Medical Corporation | Composition and methods for altering the rate of hydrolysis of cured oil-based materials |
US9867880B2 (en) | 2012-06-13 | 2018-01-16 | Atrium Medical Corporation | Cured oil-hydrogel biomaterial compositions for controlled drug delivery |
WO2016173995A1 (en) | 2015-04-28 | 2016-11-03 | Hyben Vital Licens Aps | Rose hip product comprising rose hip seeds |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4774229A (en) | 1982-04-05 | 1988-09-27 | Chemex Pharmaceuticals, Inc. | Modification of plant extracts from zygophyllaceae and pharmaceutical use therefor |
JPH062677B2 (en) * | 1984-05-26 | 1994-01-12 | 日産化学工業株式会社 | Hematopoietic organ recovery promoter |
US4565690A (en) | 1985-04-12 | 1986-01-21 | Elena Avram | Method for treating drug addiction |
US5032400A (en) * | 1989-11-02 | 1991-07-16 | Erie Laboratories | Shark liver oil and garlic oil topical analgesic |
US5431924A (en) * | 1990-11-14 | 1995-07-11 | Emu Products Western Australia Pty. Ltd. | Anti-inflammatory composition derived from emu oil |
CN1102993A (en) | 1993-12-21 | 1995-05-31 | 吴文才 | Method for making Chinese medicine herbs preparation by polyenzyme system |
US5397778A (en) * | 1994-02-25 | 1995-03-14 | New England Deaconess Hospital Corporation | Enteral formulations for treatment of inflammation and infection |
US5585118A (en) | 1995-06-02 | 1996-12-17 | Brigham And Women's Hospital | Choline in the treatment of bipolar disorder |
US5744187A (en) | 1996-12-16 | 1998-04-28 | Gaynor; Mitchel L. | Nutritional powder composition |
US5840278A (en) | 1997-02-20 | 1998-11-24 | Coleman; Thomas | Nasal spray having a mineral vitamin component, a mineral component and aloe vera |
US6024960A (en) | 1998-04-17 | 2000-02-15 | Otto Torbjorn Hansen And Marianne Hansen | Rose-hip formulations as anti-inflammatory natural medicine for alleviating/reducing symptoms associated with inflammation and arthritis |
PT1156814E (en) * | 1999-03-03 | 2004-01-30 | Eurovita A S | PHARMACEUTICAL COMPOUNDS DIETETIC SUPPLEMENTS AND COSMETIC COMPOSITIONS COMPREHENSING A FATTY ACID AND GINGER |
-
2000
- 2000-10-23 US US09/694,764 patent/US6485752B1/en not_active Expired - Lifetime
-
2001
- 2001-10-22 AU AU2002210404A patent/AU2002210404A1/en not_active Abandoned
- 2001-10-22 PT PT01978231T patent/PT1337263E/en unknown
- 2001-10-22 DK DK01978231T patent/DK1337263T3/en active
- 2001-10-22 SI SI200130826T patent/SI1337263T1/en unknown
- 2001-10-22 WO PCT/DK2001/000696 patent/WO2002034274A1/en active IP Right Grant
- 2001-10-22 ES ES01978231T patent/ES2301565T3/en not_active Expired - Lifetime
- 2001-10-22 DE DE60133030T patent/DE60133030T2/en not_active Expired - Lifetime
- 2001-10-22 EP EP01978231A patent/EP1337263B1/en not_active Expired - Lifetime
- 2001-10-22 AT AT01978231T patent/ATE387212T1/en not_active IP Right Cessation
-
2008
- 2008-05-02 CY CY20081100474T patent/CY1107930T1/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2002034274A1 (en) | 2002-05-02 |
DE60133030D1 (en) | 2008-04-10 |
PT1337263E (en) | 2008-05-09 |
ATE387212T1 (en) | 2008-03-15 |
US6485752B1 (en) | 2002-11-26 |
EP1337263A1 (en) | 2003-08-27 |
ES2301565T3 (en) | 2008-07-01 |
CY1107930T1 (en) | 2013-09-04 |
DK1337263T3 (en) | 2008-06-09 |
SI1337263T1 (en) | 2008-08-31 |
DE60133030T2 (en) | 2009-03-19 |
EP1337263B1 (en) | 2008-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002210404A1 (en) | A composition or rose hip and fish oil for alleviating joint pain and stiffness | |
YU30004A (en) | Use of flibanserin in the treatment of sexual disorders | |
AU677279B2 (en) | Application of carbamazepine and oxcarbazepine in the treatment of Parkinson's disease and Parkinsonian syndromes | |
AUPS057102A0 (en) | Compositions and methods for treatment of skin disorders | |
HUP0400548A2 (en) | Use of combinations of iop-reducing active inoredient for preparation of pharmaceutical compositions available for treatment glaucoma | |
EP0957925A4 (en) | Treatment of osteoarthritis by administering poly-n-acetyl-d-glucosamine | |
WO2001089536A3 (en) | Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders | |
WO2003066071A8 (en) | Formulations comprising psychotropic drugs and selenium | |
AU6804500A (en) | Oregano-based therapeutic composition | |
AU2001261987A1 (en) | Apoptotic entities for use in treatment of neurodegenerative and other neurological disorders | |
MA29625B1 (en) | IMMUNOGLOBULIN | |
BR0012942A (en) | Flupirtin application to reduce pain in degenerative joint diseases of dogs and cats | |
EP3508201A3 (en) | Glycine as a diet supplement for use in the treatment skin problems that result from underlying collagen disorders and and cosmetic uses thereof | |
EP1757619A3 (en) | Osteoprotegerin in milk | |
MD1140B1 (en) | Remedy possessing a regenerative and cytoprotective activity | |
AUPP379698A0 (en) | Using ngali nut oil to treat/relieve the pain of arthritis and other similar conditions | |
ES2188742T3 (en) | TRAPIDIL FOR USE IN THE THERAPY OF PATHOLOGICAL TABLES INFLUENCABLE BY IMMUNOMODULATION. | |
WO2001089538A3 (en) | Apoptotic entities for use in treatment of endothelium dysfunction disorders | |
IL129267A (en) | Pharmaceutical compositions comprising histamine and/or serotonin for treatment of urinary incontinence | |
MD2164G2 (en) | Method of treatment of ocular contusions | |
AU675281B2 (en) | Application of riluzole as a radiorestorer |